Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), Diamines and Chemicals has informed that the Company has received a Trading approval for 2,69,402 Equity shares allotted pursuant to conversion of warrants issued on preferential basis from National Stock Exchange India (‘NSE’) via letter bearing no. NSE/LIST/ 55629 dated June 11, 2026 and from BSE via letter bearing no. LOD / PREF / SV / 247/ 2026-2027 dated June 11, 2026. The above equity shares of the Company are listed and admitted to dealings on the Exchange from June 12, 2026. In respect of the above, additional disclosures as required under SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, for Granting, withdrawal, surrender, cancellation or suspension of key licenses or regulatory approvals are provided at ‘Annexure A’. The company has enclosed the Trading Approval Letter received from NSE and BSE.
The above information is a part of company’s filings submitted to BSE.
